Search

Your search keyword '"Martín-Martos, F."' showing total 44 results

Search Constraints

Start Over You searched for: Author "Martín-Martos, F." Remove constraint Author: "Martín-Martos, F."
44 results on '"Martín-Martos, F."'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

3. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

4. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

5. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

6. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

7. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

8. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

9. Timing and characteristics of venous thromboembolism after noncancer surgery

10. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

11. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

12. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

13. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

14. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

15. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

16. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

17. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

18. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

19. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

20. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

21. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

22. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

23. DVT Management and Outcome Trends, 2001 to 2014

24. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

25. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

26. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

27. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

28. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

29. Timing and characteristics of venous thromboembolism after noncancer surgery

30. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

31. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

32. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

33. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

34. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

35. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

36. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

37. DVT Management and Outcome Trends, 2001 to 2014

38. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

39. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

40. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

41. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

42. Gender differences in patients with venous thromboembolism and five common sites of cancer.

43. Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry.

44. Gender differences in cancer patients with acute venous thromboembolism.

Catalog

Books, media, physical & digital resources